ARS Pharmaceuticals, Inc. — Form D
ARS Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-03. The offering totals $20.0M, of which $8.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-10-03
- Form: D
- Accession: 0001755120-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $8.0M
- Remaining: $12.0M
- Investors: 2
- Date of first sale: 2018-09-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-322748
Issuer
- Name: ARS Pharmaceuticals, Inc.
- CIK: 0001755120
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 3525 Del Mar Heights Road #855, SAN DIEGO, CA, 92130
- Phone: 858-799-1840
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Peter Kolchinsky | Director | Boston, MA |
| Rajeev Dadoo | Director | Philadelphia, PA |
| Brent Saunders | Director | Carlsbad, CA |
| Pratik Shah | Director | George Town, Grand Cayman, E9 |
| Jonathan Leff | Director | Ness Ziona, L3 |
| Mike Kelly | Director | San Diego, CA |
| Richard Lowenthal | Director | San Diego, CA |
| Richard Lowenthal | Executive Officer | San Diego, CA |
| Dana McGowan | Executive Officer | San Diego, CA |
| Phil Schneider | Director | San Diego, CA |
Other filings by this issuer (1)
More